TWI571273B - Antibacterial catheter - Google Patents

Antibacterial catheter Download PDF

Info

Publication number
TWI571273B
TWI571273B TW103129738A TW103129738A TWI571273B TW I571273 B TWI571273 B TW I571273B TW 103129738 A TW103129738 A TW 103129738A TW 103129738 A TW103129738 A TW 103129738A TW I571273 B TWI571273 B TW I571273B
Authority
TW
Taiwan
Prior art keywords
antibacterial
carbon material
catheter
channel
catheter according
Prior art date
Application number
TW103129738A
Other languages
Chinese (zh)
Other versions
TW201607570A (en
Inventor
ze-hao Ke
Ming-Qian Hong
rui-xiang Lin
Yan-Ru Su
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to TW103129738A priority Critical patent/TWI571273B/en
Publication of TW201607570A publication Critical patent/TW201607570A/en
Application granted granted Critical
Publication of TWI571273B publication Critical patent/TWI571273B/en

Links

Landscapes

  • Materials For Medical Uses (AREA)
  • Water Treatment By Sorption (AREA)

Description

抗菌導尿管 Antibacterial catheter

本發明是關於一種導尿管,特別關於一種抗菌導尿管,可有效預防泌尿系統之細菌感染。 The invention relates to a catheter, in particular to an antibacterial catheter, which can effectively prevent bacterial infection of the urinary system.

目前市面上常見的導尿管主要是在橡膠導管上加裝一球囊,藉由因充水而膨脹的球囊使導尿管固定在膀胱內。此種導尿管因為可以長期使用,又稱為留置型導尿管。 At present, the common catheter in the market is mainly to install a balloon on the rubber catheter, and the catheter is fixed in the bladder by the balloon which is inflated by water filling. Such a catheter is also known as an indwelling catheter because it can be used for a long time.

根據統計資料顯示,有25%的醫院住院病患會使用留置型導尿管,而且每天約有3-10%的病患會發生泌尿道感染,嚴重者甚至會引發敗血症而死亡。另根據台灣地區統計,從2003年至2012年第三季,病患發生泌尿道感染的比例10年來平均高達36.5%,在各醫學中心排名第一名,故使用導尿管顯然會增加外源性細菌感染之風險。 According to statistics, 25% of inpatients in hospitals use indwelling catheters, and about 3-10% of patients will have urinary tract infections every day, and severe cases may even lead to sepsis and death. According to statistics from Taiwan, from 2003 to the third quarter of 2012, the proportion of patients with urinary tract infections averaged 36.5% in 10 years, ranking first in various medical centers, so the use of catheters will obviously increase external sources. The risk of sexual bacterial infection.

本發明之目的是提供一種抗菌導尿管,可有效抑制細菌生長,以避免泌尿系統之細菌感染問題。 The object of the present invention is to provide an antibacterial catheter which can effectively inhibit bacterial growth and avoid bacterial infection of the urinary system.

為達成前揭目的,本發明所提供之抗菌導尿管包含有一本體與一抗菌碳材,該本體具有一形成於該本體內的導尿通道、一導入口位於該導尿通道之一端、及一導出口位 於該導尿通道之另一端,該導尿通道分別與該導入口及該導出口相連通;該抗菌碳材設於該導尿通道內,該抗菌碳材之BET比表面積介於500m2/g與1800m2/g之間,且該抗菌碳材中孔徑小於2奈米之微孔容積佔總孔洞之容積比例介於30%與50%之間。 In order to achieve the foregoing object, an antibacterial catheter provided by the present invention comprises a body and an antibacterial carbon material, the body having a catheterization channel formed in the body, an introduction port at one end of the catheterization channel, and An outlet is located at the other end of the urinary passage, the urinary passage is respectively connected with the introduction port and the outlet; the antibacterial carbon material is disposed in the urinary passage, and the BET specific surface area of the antibacterial carbon material is between Between 500m 2 /g and 1800m 2 /g, and the ratio of the pore volume of the antibacterial carbon material having a pore diameter of less than 2 nm to the total pore volume is between 30% and 50%.

藉由在導尿管的導尿通道內設置具有抗菌功能的抗菌碳材,不僅可使人體外部的細菌無法經由導尿通道進入膀胱,亦可將位於膀胱內的細菌加以殺除,以有效預防泌尿系統之細菌感染,改善習知導尿管所造成的膀胱細菌感染問題。 By providing an antibacterial carbon material with antibacterial function in the catheterization channel of the catheter, not only bacteria outside the human body can enter the bladder through the catheterization channel, but also bacteria in the bladder can be eliminated to effectively prevent Bacterial infection of the urinary system improves the bacterial infection of the bladder caused by conventional catheters.

1‧‧‧本體 1‧‧‧ Ontology

11‧‧‧導入口 11‧‧‧Import

12‧‧‧導尿通道 12‧‧‧ catheterization

13‧‧‧引流通道 13‧‧‧Drainage channel

14‧‧‧導出口 14‧‧‧Export

15‧‧‧注射口 15‧‧‧ injection port

2‧‧‧抗菌碳材 2‧‧‧Antibacterial carbon material

21‧‧‧抗菌通道 21‧‧ ‧Antibacterial channel

22‧‧‧延伸部 22‧‧‧Extension

23‧‧‧固接部 23‧‧‧Fixed Department

3‧‧‧球囊 3‧‧‧ balloon

第1圖為本發明抗菌導尿管之第一較佳實施例之剖視圖。 BRIEF DESCRIPTION OF THE DRAWINGS Figure 1 is a cross-sectional view showing a first preferred embodiment of the antibacterial catheter of the present invention.

第2圖為本發明測試例1之抗菌碳材吸附大腸桿菌初始狀態之電子顯微鏡(SEM)照片。 Fig. 2 is an electron microscope (SEM) photograph of the initial state of adsorption of Escherichia coli by the antibacterial carbon material of Test Example 1 of the present invention.

第3圖為本發明測試例1之抗菌碳材吸附大腸桿菌經過24小時之後的電子顯微鏡(SEM)照片。 Fig. 3 is an electron microscope (SEM) photograph of the antibacterial carbon material of Test Example 1 of the present invention after 24 hours of adsorption of Escherichia coli.

第4圖為本發明測試例2之抗菌碳材吸附大腸桿菌初始狀態之電子顯微鏡(SEM)照片。 Fig. 4 is an electron microscope (SEM) photograph of the initial state of adsorption of Escherichia coli by the antibacterial carbon material of Test Example 2 of the present invention.

第5圖為本發明測試例2之抗菌碳材吸附大腸桿菌經過24小時之後的電子顯微鏡(SEM)照片。 Fig. 5 is a photomicrograph (SEM) photograph of the antibacterial carbon material of Test Example 2 of the present invention after 24 hours of adsorption of Escherichia coli.

第6圖為本發明抗菌導尿管之第二較佳實施例之剖視圖。 Figure 6 is a cross-sectional view showing a second preferred embodiment of the antibacterial catheter of the present invention.

第7圖為本發明抗菌導尿管之第三較佳實施例之剖視圖。 Figure 7 is a cross-sectional view showing a third preferred embodiment of the antibacterial catheter of the present invention.

如圖1所示,本發明抗菌導尿管之第一較佳實施例包含一本體1、以及一設於該本體1內的抗菌碳材2。該抗菌導尿管適用於被置入一病患之膀胱,其中,該本體1之前段連同該抗菌碳材2係置於該膀胱內,而該本體1之中後段則位於人體外。 As shown in FIG. 1, a first preferred embodiment of the antibacterial catheter of the present invention comprises a body 1, and an antibacterial carbon material 2 disposed in the body 1. The antibacterial catheter is adapted to be placed in a bladder of a patient, wherein the front portion of the body 1 together with the antibacterial carbon material 2 is placed in the bladder, and the rear portion of the body 1 is located outside the human body.

該本體1為可撓材質如矽膠或聚氯乙烯所製成,並包括一導入口11、一導尿通道12、一導出口14、一球囊3、一引流通道13,及一注射口15。導尿通道12係形成於該本體1內,該導入口11位於該導尿通道12之前端,用於供該膀胱內之尿液導入該導尿通道12,該導出口14位於該導尿通道12之後端,該導尿通道12分別與該導入口11及該導出口14相連通,該導出口14位於人體外,可將該導尿通道之尿液導出至一尿液蒐集袋中。該球囊3設於該導尿通道12外且鄰近該導入口11,該引流通道13與該導尿通道12併排且互不相通,該注射口15、該引流通道13及該球囊3三者相連通,且該注射口15係供一針筒連接,以便醫護人員注入生理食鹽水將該球囊3充滿而使其膨脹,藉此將該球囊3及該本體1之前段固定在病患之膀胱內,使得該抗菌導尿管不會因為受到拉扯或其他因素而脫落。 The body 1 is made of a flexible material such as silicone or polyvinyl chloride, and includes an introduction port 11, a catheterization channel 12, an outlet port 14, a balloon 3, a drainage channel 13, and an injection port 15. . A catheterization channel 12 is formed in the body 1. The introduction port 11 is located at the front end of the catheterization channel 12 for introducing urine in the bladder into the catheterization channel 12, and the outlet port 14 is located in the catheterization channel. At the rear end of the 12, the catheterization channel 12 is in communication with the introduction port 11 and the outlet port 14, respectively. The outlet port 14 is located outside the human body, and the urine of the catheter channel can be exported to a urine collection bag. The balloon 3 is disposed outside the catheterization channel 12 and adjacent to the introduction port 11 . The drainage channel 13 is adjacent to the catheter channel 12 and is not in communication with each other. The injection port 15 , the drainage channel 13 and the balloon 3 are three The injection port 15 is connected by a syringe, so that the medical staff injects the physiological saline to fill the balloon 3 and expands it, thereby fixing the balloon 3 and the front portion of the body 1 to the disease. In the bladder, the antibacterial catheter does not fall off due to pulling or other factors.

該抗菌碳材2設於該導尿通道12最前端且接近該 導入口11處,並具有一與該導入口11及該導尿通道12相連通的抗菌通道21。當尿液自該導入口11進入該本體1內時,會先流經該抗菌通道21,接著經由該導尿通道12由該導出口14流出。因此,當外部之細菌欲經由尿液或導尿通道12進入膀胱時,便會被該抗菌碳材2吸附並滅除。值得注意的是,該抗菌碳材2可為聚丙烯腈(PAN)活性碳、竹炭或石墨烯,且該抗菌碳材可以是織物狀、非織物狀或粉末狀。若該抗菌碳材為粉末狀,則單顆粉粒之長度為10-300μm,直徑為5-15μm。該抗菌碳材2之BET比表面積介於500m2/g與1800m2/g之間,且該活性碳材中孔徑小於2奈米之微孔容積佔總孔洞之容積比例介於30%與50%之間。 The antibacterial carbon material 2 is disposed at the foremost end of the urinary catheter 12 and adjacent to the introduction port 11, and has an antibacterial channel 21 communicating with the introduction port 11 and the urinary catheter channel 12. When the urine enters the body 1 from the introduction port 11, it flows through the antibacterial channel 21 first, and then flows out through the outlet port 14 via the catheter channel 12. Therefore, when the external bacteria wants to enter the bladder through the urine or the catheterization passage 12, it is adsorbed and eliminated by the antimicrobial carbon material 2. It should be noted that the antibacterial carbon material 2 may be polyacrylonitrile (PAN) activated carbon, bamboo charcoal or graphene, and the antibacterial carbon material may be woven, non-woven or powdery. If the antibacterial carbon material is in the form of a powder, the individual particles have a length of 10 to 300 μm and a diameter of 5 to 15 μm. The antibacterial carbon material 2 has a BET specific surface area of between 500 m 2 /g and 1800 m 2 /g, and the pore volume of the activated carbon material having a pore diameter of less than 2 nm accounts for 30% and 50% of the total pore volume. %between.

為了解本發明所述之抗菌碳材2之抗菌特性,茲採用如下設備與方法進行測量及觀察:碳材表面觀察儀器為冷場發射掃描式電子顯微鏡及能量散佈光譜儀(Cold Field Emission Scanning Electron Microscope and Energy Dispersive Spectrometer),日本HITACHI公司製造,型號為S-4800。測試方法係以碳膠帶將適當大小之碳材固定於載台上(直徑2.5公分),放置於80℃加熱盤上烘1小時。使用10至15kv之加速電壓,5000倍之放大倍率進行碳材之表面觀察。 In order to understand the antibacterial properties of the antibacterial carbon material 2 of the present invention, the following equipment and methods are used for measurement and observation: the carbon surface observation instrument is a cold field emission scanning electron microscope and an energy dispersive spectrometer (Cold Field Emission Scanning Electron Microscope and Energy Dispersive Spectrometer), manufactured by HITACHI, Japan, model number S-4800. The test method was to fix a suitable size of carbon material on a stage (2.5 cm in diameter) with a carbon tape, and place it on a heating plate at 80 ° C for 1 hour. The surface of the carbon material was observed using an acceleration voltage of 10 to 15 kV and a magnification of 5000 times.

比表面積(BET)分析設備為Micromeritics公司製造之Micromeritics ASAP2020,側試方法係將樣品先經由高溫 (360℃)抽真空後,填入吸附氣體(氮氣),實驗溫度與壓力固定在77K及760mm-Hg。 The specific surface area (BET) analysis equipment is Micromeritics ASAP2020 manufactured by Micromeritics, Inc., and the side test method is to pass the sample through the high temperature first. After vacuuming (360 ° C), the adsorption gas (nitrogen) was filled in, and the experimental temperature and pressure were fixed at 77 K and 760 mm-Hg.

抗菌分析前將測試樣品取直徑4.8±0.1cm圓形樣品6片,再以121℃及103kPa(1.05kg/m2)滅菌20分鐘,並根據AATCC 100-1998抗菌測試標準規範進行測試。 Before the antibacterial analysis, the test sample was taken into a circular sample of 4.8 ± 0.1 cm in diameter, and then sterilized at 121 ° C and 103 kPa (1.05 kg / m 2 ) for 20 minutes, and tested according to the AATCC 100-1998 antibacterial test standard specification.

測試例1使用聚丙烯腈氧化纖維布進行活化處理,於氮氣保護下,以4℃/min之升溫速率,由室溫升至1000℃後,進行水蒸氣活化歷時10分鐘,再以10℃/min之降溫速率降至室溫。最後製成聚丙烯腈系活性碳纖維布,其BET比表面積值為1050m2/g,且孔徑小於2奈米之微孔容積佔總孔洞之容積比例為45%,將上述活性碳纖維布製成抗菌碳材2,以進行後續抗菌測試。 In Test Example 1, the activation treatment was carried out using a polyacrylonitrile oxidized fiber cloth, and under steam protection, the temperature was raised from room temperature to 1000 ° C at a heating rate of 4 ° C/min, and steam activation was carried out for 10 minutes, and then at 10 ° C / The cooling rate of min is reduced to room temperature. Finally, a polyacrylonitrile-based activated carbon fiber cloth having a BET specific surface area value of 1050 m 2 /g and a pore volume of less than 2 nm and a volume ratio of the total pores of 45% is prepared, and the activated carbon fiber cloth is made into an antibacterial carbon. Material 2 for subsequent antimicrobial testing.

測試例2係將測試例1所製成之活性碳纖維布含浸於0.01M硝酸銀水溶液中,同時以50rpm轉速進行攪拌0.5小時,之後進行脫水,並於120℃下進行烘乾除去水分,接著於氮氣保護下,以4℃/min之升溫速率,由室溫升至600℃後,進行熱裂解歷時1分鐘,再以10℃/min之降溫速率降至室溫。接著進行水洗2小時,再於120℃下進行烘乾2小時,而製得最後之成品。其中銀佔總重量之0.06wt%,且於活性碳纖維上之銀顆粒大小為奈米級,其粒徑約為10至50nm。載有銀顆粒之活性碳纖維布,其真密度為2.06g/cm3,碳含量為85.5wt%,氧含量為10.4wt%,BET比表面積為1030m2/g,孔徑小於2奈米之 微孔容積佔總孔洞之容積比例為44%,將上述載有銀顆粒之活性碳纖維布製成抗菌碳材2,以進行後續抗菌測試,其結果如表一所示。 In Test Example 2, the activated carbon fiber cloth prepared in Test Example 1 was impregnated in a 0.01 M aqueous solution of silver nitrate while stirring at 50 rpm for 0.5 hour, followed by dehydration, and drying at 120 ° C to remove moisture, followed by nitrogen gas. Under the protection, at a heating rate of 4 ° C / min, from room temperature to 600 ° C, thermal cracking was carried out for 1 minute, and then reduced to room temperature at a temperature drop rate of 10 ° C / min. Then, it was washed with water for 2 hours, and then dried at 120 ° C for 2 hours to obtain a final product. Silver accounts for 0.06 wt% of the total weight, and the silver particles on the activated carbon fibers are nanometer in size and have a particle diameter of about 10 to 50 nm. Activated carbon fiber cloth loaded with silver particles having a true density of 2.06 g/cm 3 , a carbon content of 85.5 wt%, an oxygen content of 10.4 wt%, a BET specific surface area of 1030 m 2 /g, and a pore diameter of less than 2 nm. The volume ratio of the volume to the total pores was 44%, and the above-mentioned activated carbon fiber cloth carrying silver particles was made into the antibacterial carbon material 2 for subsequent antibacterial test, and the results are shown in Table 1.

根據AATCC 100規範測試測試例1及測試例2的抗菌能力,其中測試例1對金黃色葡萄球菌的抗菌率為99.3%,對綠膿桿菌的抗菌率為99.0%。第2圖為測試例1之抗菌碳材吸附大腸桿菌初始狀態之電子顯微鏡照片,第3圖為測試例1之抗菌碳材吸附大腸桿菌經過24小時之後的電子顯微鏡照片,兩相比對,大腸桿菌之數量明顯減少。測試例2將活性碳纖維布載上0.06wt%的銀後整個抗菌性能可以提升到99.99%以上,第4圖係本發明測試例2之抗菌碳材吸附大腸桿 菌初始狀態之電子顯微鏡照片,第5圖則為測試例2之抗菌碳材吸附大腸桿菌經過24小時之後的電子顯微鏡照片,顯示原先的大腸桿菌已陸續在該抗菌碳材上死亡,表示銀可輔助PAN活性碳纖維進行殺菌,提高抗菌率。 The antibacterial ability of Test Example 1 and Test Example 2 was tested according to the AATCC 100 specification, wherein the antibacterial rate of Test Example 1 against S. aureus was 99.3%, and the antibacterial rate against Pseudomonas aeruginosa was 99.0%. Fig. 2 is an electron micrograph of the initial state of adsorption of Escherichia coli by the antibacterial carbon material of Test Example 1, and Fig. 3 is an electron micrograph of the antibacterial carbon material of Test Example 1 after 24 hours of adsorption of Escherichia coli. The number of bacilli is significantly reduced. In Test Example 2, the entire antibacterial property of the activated carbon fiber cloth was increased to 99.99% or more after loading 0.06 wt% of silver. FIG. 4 is an adsorption of the intestinal rod of the antibacterial carbon material of Test Example 2 of the present invention. Electron micrograph of the initial state of the bacteria, and Fig. 5 is an electron micrograph of the antibacterial carbon material of Test Example 2 after 24 hours of adsorption of Escherichia coli, showing that the original E. coli has successively died on the antibacterial carbon material, indicating that silver can be The auxiliary PAN activated carbon fiber is sterilized to increase the antibacterial rate.

為了解抗菌碳材的比表面積大小對抗菌性能之影響,將聚丙烯腈氧化纖維布分別在600℃、800℃與1200℃之活化溫度下製成聚丙烯腈(PAN)活性碳纖維並製成抗菌碳材,依活化溫度低到高分別命名為對照組、測試例3及測試例4,其活化處理條件如測試例1,僅改變活化溫度,經測量其BET比表面積分別為380m2/g、650m2/g與1800m2/g,且孔徑小於2奈米之微孔容積佔總孔洞之容積比例分別為27%、41%與48%。 In order to understand the effect of the specific surface area of the antibacterial carbon material on the antibacterial property, the polyacrylonitrile (PAN) activated carbon fiber was made into an antibacterial carbon at a activation temperature of 600 ° C, 800 ° C and 1200 ° C, respectively. The materials were named as the control group, Test Example 3 and Test Example 4 according to the activation temperature, and the activation treatment conditions were as in Test Example 1, only the activation temperature was changed, and the BET specific surface areas were measured to be 380 m 2 /g, 650 m, respectively. 2 / g and 1800 m 2 / g, and the pore volume of the pores less than 2 nm accounted for 27%, 41% and 48% of the total pore volume, respectively.

根據AATCC 100所規範的測試方法測試對照組、測試例3及測試例4之抗菌能力,結果如下表2之抗菌性能測試結果表,由表2顯示對照組之BET比表面積低且微孔容積比低,其抗菌能力明顯不如BET比表面積高之測試例3與測試例4。 The antibacterial ability of the control group, the test sample 3, and the test sample 4 was tested according to the test method specified in AATCC 100. The results are shown in Table 2 below. The results of Table 2 show that the control group has a low BET specific surface area and a micropore volume ratio. Low, the antibacterial ability was significantly inferior to Test Example 3 and Test Example 4 where the BET specific surface area was high.

歸納以上實驗測試結果,可得抗菌碳材之BET比表面積介於500m2/g與1800m2/g之間,且該抗菌碳材中孔徑小於2奈米之微孔容積佔總孔洞之容積比例介於30%與50%之間,時其抗菌能力較佳,其中以抗菌碳材之BET比表面積介於650m2/g與1800m2/g之間其抗菌能力更佳。 By summarizing the above experimental test results, the BET specific surface area of the antibacterial carbon material is between 500 m 2 /g and 1800 m 2 /g, and the volume ratio of the micropore volume of the antibacterial carbon material having a pore diameter of less than 2 nm to the total pore volume is obtained. between 30% and 50% range, preferably in its antimicrobial activity, wherein the carbon material of the antibacterial BET better antibacterial ability between 650m 2 / g to 1800m 2 / g specific surface area is between.

為進一步加強該抗菌碳材2之抗菌能力,可施予有機或無機抗菌處理。於有機抗菌處理中,可以含浸或塗抹氨基醣苷類(aminoglycoside)物質,例如慶大黴素(gentamicin)、妥布黴素(tobramycin),丁胺卡那黴素(amikacin)等,使該抗菌碳材2與上述有機物質結合,最後形成具有高抗菌能力之材料。因此,將經過有機抗菌處理的抗菌碳材2應用於該導尿管中即可有效預防泌尿系統之細菌感染。其中,使用慶大黴素進行有機抗菌處理的效果為較佳。 In order to further enhance the antibacterial ability of the antibacterial carbon material 2, an organic or inorganic antibacterial treatment can be applied. In the organic antibacterial treatment, an aminoglycoside substance such as gentamicin, tobramycin, amikacin or the like may be impregnated or coated to make the antibacterial carbon. The material 2 is combined with the above organic substance to finally form a material having high antibacterial ability. Therefore, the application of the antibacterial carbon material 2 subjected to the organic antibacterial treatment to the catheter can effectively prevent bacterial infection of the urinary system. Among them, the effect of using gentamicin for organic antibacterial treatment is preferred.

於無機抗菌處理中,可將該抗菌碳材2以含浸、塗佈、電鍍、蒸鍍、化學氣相沉積、無電鍍等技術,將金、銀、銅或鋅等無機抗菌金屬結合在該抗菌碳材2上,最後形成具有高抗菌能力之材料。該抗菌碳材中金、銀、銅或鋅之含量為0.01~0.1wt%。因此,將經過無機抗菌處理的抗菌碳材2應用於該導尿管中即可有效預防泌尿系統之細菌感染。其中,使用銀或銅進行無機抗菌處理的效果為較佳。 In the inorganic antibacterial treatment, the antibacterial carbon material 2 may be combined with an inorganic antibacterial metal such as gold, silver, copper or zinc by the techniques of impregnation, coating, electroplating, vapor deposition, chemical vapor deposition, electroless plating, and the like. On the carbon material 2, a material having high antibacterial ability is finally formed. The content of gold, silver, copper or zinc in the antibacterial carbon material is 0.01 to 0.1% by weight. Therefore, the application of the inorganic antibacterial-treated antibacterial carbon material 2 to the catheter can effectively prevent bacterial infection of the urinary system. Among them, the effect of inorganic antibacterial treatment using silver or copper is preferred.

關於該抗菌碳材2之具體結構實施態樣,可將一活性碳纖維布捲成柱狀以形成該抗菌碳材2,或於該本體1之內壁沾黏由上述活性碳纖維研磨而成之粉末以形成該抗菌碳材2,亦可於PU發泡材料之發泡過程中加入上述活性碳纖維以形成棒狀之抗菌碳材2。 Regarding the specific structural embodiment of the antibacterial carbon material 2, an activated carbon fiber cloth may be wound into a columnar shape to form the antibacterial carbon material 2, or the inner wall of the body 1 may be adhered to a powder obtained by grinding the activated carbon fiber. In order to form the antibacterial carbon material 2, the activated carbon fiber may be added to the foaming process of the PU foaming material to form a rod-shaped antibacterial carbon material 2.

如第6圖所示,係本發明抗菌導尿管之第二較佳實施例,其大致與第一較佳實施例相同,其差異在於:該抗菌碳材2係多孔性且塞設於接近該導出口14處,使得進入該本體1內的尿液自該導尿通道12依序經過該抗菌碳材2與該導出口14而向外流出。因此,當外部之細菌欲以尿液或導尿管為媒介進入膀胱時,便會吸附於該抗菌碳材2,並於吸附一段時間後死亡,使該抗菌碳材2發揮其抗菌與阻絕之功效。 As shown in Fig. 6, a second preferred embodiment of the antibacterial catheter of the present invention is substantially the same as the first preferred embodiment, except that the antibacterial carbon material 2 is porous and plugged close to The outlet 14 is such that urine entering the body 1 flows out of the urinary passage 12 through the antibacterial carbon material 2 and the outlet 14 in an outward direction. Therefore, when the external bacteria wants to enter the bladder with urine or a catheter as a medium, it will adsorb to the antibacterial carbon material 2 and die after a certain period of adsorption, so that the antibacterial carbon material 2 exerts its antibacterial and resistance. efficacy.

如第7圖所示,係本發明抗菌導尿管之第三較佳實施例,其大致與第一較佳實施例相同,其差異在於:該抗菌碳材2一端具有一固接部23設於該導尿通道12最前端接近該導入口11處,並具有一自該固接部23沿該導尿通道12長度方向延伸的延伸部22。在本實施例中,該延伸部22呈柱狀或棒狀。因此,當外部之細菌欲以尿液或導尿管為媒介進入膀胱時,便會吸附於該抗菌碳材2的延伸部22,並於吸附一段時間後死亡,使該抗菌碳材2發揮其抗菌與阻絕之功效。 As shown in FIG. 7, a third preferred embodiment of the antibacterial catheter of the present invention is substantially the same as the first preferred embodiment, and the difference is that the antibacterial carbon material 2 has a fixing portion 23 at one end. The leading end of the urinary catheter 12 is adjacent to the introduction port 11 and has an extending portion 22 extending from the fixing portion 23 along the longitudinal direction of the urinary catheter channel 12. In the present embodiment, the extending portion 22 has a columnar shape or a rod shape. Therefore, when the external bacteria wants to enter the bladder with urine or a catheter as a medium, it will adsorb to the extension portion 22 of the antibacterial carbon material 2, and will die after a certain period of adsorption, so that the antibacterial carbon material 2 exerts its Antibacterial and blocking effects.

綜上所述,本發明之優點在於:藉由在導尿管的導尿通道12內設置具有抗菌功能的抗菌碳材2,即積極地對於 細菌之傳遞路徑予以阻斷,使得人體外部的細菌無法以尿液或該導尿管為媒介進入膀胱,可有效預防泌尿系統之細菌感染,避免習知長期留置型導尿管所造成的細菌性膀胱炎等問題。 In summary, the present invention has an advantage in that an antibacterial carbon material 2 having an antibacterial function is provided in the catheterization channel 12 of the catheter, that is, actively The path of bacteria is blocked, so that bacteria outside the body can not enter the bladder with urine or the catheter as a medium, which can effectively prevent bacterial infection of the urinary system and avoid the bacteriality caused by the long-term indwelling catheter. Cystitis and other issues.

1‧‧‧本體 1‧‧‧ Ontology

11‧‧‧導入口 11‧‧‧Import

12‧‧‧導尿通道 12‧‧‧ catheterization

13‧‧‧引流通道 13‧‧‧Drainage channel

14‧‧‧導出口 14‧‧‧Export

15‧‧‧注射口 15‧‧‧ injection port

2‧‧‧抗菌碳材 2‧‧‧Antibacterial carbon material

21‧‧‧抗菌通道 21‧‧ ‧Antibacterial channel

3‧‧‧球囊 3‧‧‧ balloon

Claims (10)

一種抗菌導尿管,包含有:一本體,具有一形成於該本體內的導尿通道、一導入口位於該導尿通道之一端、及一導出口位於該導尿通道之另一端,該導尿通道分別與該導入口及該導出口相連通;以及一設於該導尿通道內的抗菌碳材,該抗菌碳材之BET比表面積介於500m2/g與1800m2/g之間,且該抗菌碳材中孔徑小於2奈米之微孔容積佔總孔洞之容積比例介於30%與50%之間。 An antibacterial catheter comprises: a body having a catheterization channel formed in the body, an introduction port at one end of the catheterization channel, and an outlet at the other end of the catheterization channel, the guide The urinary passage is respectively connected to the introduction port and the outlet; and an antibacterial carbon material disposed in the urinary passage, the BET specific surface area of the antibacterial carbon material is between 500 m 2 /g and 1800 m 2 /g, And the volume ratio of the micropore volume of the antibacterial carbon material having a pore diameter of less than 2 nm to the total pore volume is between 30% and 50%. 根據申請專利範圍第1項之抗菌導尿管,其中,該抗菌碳材之材質為PAN活性碳、竹炭或石墨烯。 The antibacterial catheter according to the first aspect of the invention, wherein the antibacterial carbon material is made of PAN activated carbon, bamboo charcoal or graphene. 根據申請專利範圍第2項之抗菌導尿管,其中,該抗菌碳材為織物狀、非織物狀或粉末狀。 An antibacterial catheter according to the second aspect of the invention, wherein the antibacterial carbon material is in the form of a woven fabric, a non-woven fabric or a powder. 根據申請專利範圍第1項之抗菌導尿管,其中,該抗菌碳材之BET比表面積介於650m2/g與1800m2/g之間。 The scope of the patent antimicrobial catheter, Paragraph 1, wherein, the antimicrobial a BET specific surface area of the carbon material between 650m 2 / g to 1800m 2 / g range. 根據申請專利範圍第1項之抗菌導尿管,其中該本體更具有一球囊設於該導尿通道外且鄰近該導入口、一引流通道及一注射口,該引流通道與該導尿通道併排且互不相通,該注射口、該引流通道及該球囊三者相連通。 The antibacterial catheter according to claim 1, wherein the body further has a balloon disposed outside the catheter and adjacent to the inlet, a drainage channel and an injection port, the drainage channel and the catheter channel Side by side and not in communication with each other, the injection port, the drainage channel and the balloon are connected. 根據申請專利範圍第1項之抗菌導尿管,其中該抗菌碳材設於接近該導入口處。 An antibacterial catheter according to the first aspect of the invention, wherein the antibacterial carbon material is disposed near the inlet. 根據申請專利範圍第6項之抗菌導尿管,其中該抗菌碳材具有一與該導入口及該導尿通道相連通的抗菌通道。 An antibacterial catheter according to the sixth aspect of the invention, wherein the antibacterial carbon material has an antibacterial passage communicating with the introduction port and the catheter. 根據申請專利範圍第1項之抗菌導尿管,其中該抗菌碳材設於接近該導出口處。 An antibacterial catheter according to the first aspect of the invention, wherein the antibacterial carbon material is disposed near the outlet. 根據申請專利範圍第1項之抗菌導尿管,其中該抗菌碳材具有一固接部設於該本體且接近該導入口,以及一自該固接部沿該導尿通道長度方向延伸的延伸部。 The antibacterial catheter according to the first aspect of the invention, wherein the antibacterial carbon material has a fixing portion disposed on the body and adjacent to the introduction port, and an extension extending from the fixing portion along the length of the catheter channel unit. 根據申請專利範圍第1項之抗菌導尿管,其中該抗菌碳材含有0.01~0.1wt%的金、銀、銅或鋅。 The antibacterial catheter according to the first aspect of the invention, wherein the antibacterial carbon material contains 0.01 to 0.1% by weight of gold, silver, copper or zinc.
TW103129738A 2014-08-28 2014-08-28 Antibacterial catheter TWI571273B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW103129738A TWI571273B (en) 2014-08-28 2014-08-28 Antibacterial catheter

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW103129738A TWI571273B (en) 2014-08-28 2014-08-28 Antibacterial catheter

Publications (2)

Publication Number Publication Date
TW201607570A TW201607570A (en) 2016-03-01
TWI571273B true TWI571273B (en) 2017-02-21

Family

ID=56084562

Family Applications (1)

Application Number Title Priority Date Filing Date
TW103129738A TWI571273B (en) 2014-08-28 2014-08-28 Antibacterial catheter

Country Status (1)

Country Link
TW (1) TWI571273B (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007075352A (en) * 2005-09-14 2007-03-29 Olympus Corp Medical coating agent, medical member and its production method
CN103482599A (en) * 2013-09-04 2014-01-01 李力 Nano-carbon sol and application thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007075352A (en) * 2005-09-14 2007-03-29 Olympus Corp Medical coating agent, medical member and its production method
CN103482599A (en) * 2013-09-04 2014-01-01 李力 Nano-carbon sol and application thereof

Also Published As

Publication number Publication date
TW201607570A (en) 2016-03-01

Similar Documents

Publication Publication Date Title
TWI541010B (en) A tampon structure
Wan et al. Scalable synthesis of robust and stretchable composite wound dressings by dispersing silver nanowires in continuous bacterial cellulose
CN105412995A (en) Medical catheter and method for forming antibacterial hydrophilic coating on surface of medical catheter
CN109568634B (en) Reduced graphene oxide antibacterial dressing and preparation method thereof
CN108621481B (en) Antibacterial fabric containing silver ions and antibacterial textile
CN102631699A (en) Antibacterial fiber dressing containing nanometer metal and preparation method thereof
CN105597159A (en) Gold nano-particle based antibacterial product and preparation method and application thereof
CN104784736A (en) Compound silver-zinc antibacterial composition-containing activated carbon fiber dressing and preparation method thereof
JPWO2011118680A1 (en) Antibacterial medical device manufacturing method and antibacterial medical device
Rather et al. Polyurethane and cellulose acetate micro-nanofibers containing rosemary essential oil, and decorated with silver nanoparticles for wound healing application
CN105218810B (en) A kind of antibacterial super slippery medical material and preparation method thereof and antibacterial super slippery urethral catheter
US20160166802A1 (en) Antibacterial catheter
Li et al. Chitosan-based antibacterial microspheres loaded multifunctional Janus composite membranes with unidirectional biofluid transport, antioxidant and pH-responsive monitoring
CN113622193B (en) Antibacterial pillow
TWI571273B (en) Antibacterial catheter
CN114010845A (en) Near-infrared light response antibacterial coating and preparation method thereof
TWM494000U (en) Antibacterial urinary catheter
CN104225762A (en) Antibacterial urethral catheter
Kim et al. Thermal fabrication and characterization of Ag nanoparticle-activated carbon composites for functional wound-dressing additives
CN109758620B (en) Long-acting antibacterial degradable ureteral stent and preparation method thereof
CN106902440B (en) A kind of medical drainage tube of Internal Medicine-Oncology
CN201949389U (en) Antibacterial medical catheter with nano silver/polymer honeycomb films
US20180344636A1 (en) Method for manufacturing an anti-vaginitis suppository
CN110604822B (en) Magnetic antibacterial nano system and preparation method thereof
CN105496475A (en) Antibacterial intervention medical instrument

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees